α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice. [PDF]
Rodríguez-Castejón J +6 more
europepmc +1 more source
α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes. [PDF]
Jehn U +7 more
europepmc +1 more source
Human α-Galactosidase A Mutants: Priceless Tools to Develop Novel Therapies for Fabry Disease. [PDF]
Modrego A +5 more
europepmc +1 more source
Identification and Characterization of a Thermostable GH36 α-Galactosidase from Anoxybacillusvitaminiphilus WMF1 and Its Application in Synthesizing Isofloridoside by Reverse Hydrolysis. [PDF]
Wang J, Cao X, Chen W, Xu J, Wu B.
europepmc +1 more source
Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort. [PDF]
Maruyama H +18 more
europepmc +1 more source
Human α-galactosidase A is stimulated by folic acid supplementation - possible implications in Fabry disease management. [PDF]
Khatoon S, Junaid MA.
europepmc +1 more source
Key considerations for measuring α-galactosidase A activity after long-term migalastat therapy-Avoiding in vitro inhibition effects. [PDF]
Munakata M +4 more
europepmc +1 more source
Expression, Purification, and Functional Exploration of an α-Galactosidase from <i>Akkermansia muciniphila</i>. [PDF]
Zuo T +6 more
europepmc +1 more source
The Relative Abundances of Human Leukocyte Antigen-E, α-Galactosidase A and α-Gal Antigenic Determinants Are Biased by Trichostatin A-Dependent Epigenetic Transformation of Triple-Transgenic Pig-Derived Dermal Fibroblast Cells. [PDF]
Samiec M +9 more
europepmc +1 more source
Bioinformatics-Driven Multi-Factorial Insight into α-Galactosidase Mutations. [PDF]
Hay Mele B +5 more
europepmc +1 more source

